These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27257033)

  • 41. A prospective study of screening for hypertensive disorders of pregnancy at 11-13 weeks in a Scandinavian population.
    Skråstad RB; Hov GG; Blaas HG; Romundstad PR; Salvesen KÅ
    Acta Obstet Gynecol Scand; 2014 Dec; 93(12):1238-47. PubMed ID: 25146367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation.
    Pilalis A; Souka AP; Antsaklis P; Daskalakis G; Papantoniou N; Mesogitis S; Antsaklis A
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):135-40. PubMed ID: 17221926
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The utility of first trimester uterine artery Doppler, placental volume and PAPP-A levels alone and in combination to predict preeclampsia.
    Yücel B; Gedikbasi A; Dündar O; Olgac Y; Yıldırım D; Yıldırım G; Polat I
    Pregnancy Hypertens; 2016 Oct; 6(4):269-273. PubMed ID: 27939466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study.
    Myers JE; Kenny LC; McCowan LM; Chan EH; Dekker GA; Poston L; Simpson NA; North RA;
    BJOG; 2013 Sep; 120(10):1215-23. PubMed ID: 23906160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of screening for pre-eclampsia at 31-34 weeks' gestation by sFlt-1/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGF.
    Tan MY; Wright D; Koutoulas L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Feb; 49(2):201-208. PubMed ID: 27671370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia.
    Odibo AO; Rada CC; Cahill AG; Goetzinger KR; Tuuli MG; Odibo L; Macones GA; England SK
    J Perinatol; 2013 Sep; 33(9):670-4. PubMed ID: 23558430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation.
    Litwinska M; Wright D; Efeturk T; Ceccacci I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):367-372. PubMed ID: 28133831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. First trimester screening for preterm and term pre-eclampsia by maternal characteristics and biophysical markers in a low-risk population.
    Sepúlveda-Martínez A; Rencoret G; Silva MC; Ahumada P; Pedraza D; Muñoz H; Valdés E; Parra-Cordero M
    J Obstet Gynaecol Res; 2019 Jan; 45(1):104-112. PubMed ID: 30230132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia.
    Poon LC; Maiz N; Valencia C; Plasencia W; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Jan; 33(1):23-33. PubMed ID: 19090499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uterine and umbilical artery Doppler at 28 weeks for predicting adverse pregnancy outcomes in women with abnormal uterine artery Doppler findings in the early second trimester.
    Ventura W; De Paco Matallana C; Prieto-Sanchez MT; Macizo MI; Pertegal M; Nieto A; Delgado JL
    Prenat Diagn; 2015 Mar; 35(3):294-8. PubMed ID: 25483940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
    Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
    Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uterine Artery Pulsatility Index as a Pre-eclampsia Predictor in the 3 Trimesters in Women with Singleton Pregnancies.
    Guzmán YN; Uriel M; Ramírez AP; Romero XC
    Rev Bras Ginecol Obstet; 2021 Dec; 43(12):904-910. PubMed ID: 34933383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive value of ophthalmic artery Doppler velocimetry in relation to development of pre-eclampsia.
    Matias DS; Costa RF; Matias BS; Gordiano L; Correia LC
    Ultrasound Obstet Gynecol; 2014 Oct; 44(4):419-26. PubMed ID: 24478256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of pre-eclampsia combining NGAL and other biochemical markers with Doppler in the first and/or second trimester of pregnancy. A pilot study.
    Karampas GA; Eleftheriades MI; Panoulis KC; Rizou MD; Haliassos AD; Metallinou DK; Mastorakos GP; Rizos DA
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():153-7. PubMed ID: 27599094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uterine artery Doppler and biochemical markers (PAPP-A, PIGF, sFlt-1, P-selectin, NGAL) at 11 + 0 to 13 + 6 weeks in the prediction of late (> 34 weeks) pre-eclampsia.
    Youssef A; Righetti F; Morano D; Rizzo N; Farina A
    Prenat Diagn; 2011 Dec; 31(12):1141-6. PubMed ID: 22034048
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Value of placental volume and vascular flow indices as predictors of intrauterine growth retardation.
    González-González NL; González-Dávila E; González Marrero L; Padrón E; Conde JR; Plasencia W
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():13-19. PubMed ID: 28327375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia.
    Foidart JM; Munaut C; Chantraine F; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2010 Jun; 35(6):680-7. PubMed ID: 20205159
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of aspirin on trophoblastic invasion in women with abnormal uterine artery Doppler at 11-14 weeks: a randomized controlled study.
    Scazzocchio E; Oros D; Diaz D; Ramirez JC; Ricart M; Meler E; González de Agüero R; Gratacos E; Figueras F
    Ultrasound Obstet Gynecol; 2017 Apr; 49(4):435-441. PubMed ID: 27807890
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in uterine artery Doppler velocimetry and circulating angiogenic factors in the first half of pregnancies delivering a small-for-gestational-age neonate.
    Triunfo S; Crovetto F; Rodriguez-Sureda V; Scazzocchio E; Crispi F; Dominguez C; Gratacos E; Figueras F
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):357-363. PubMed ID: 27241056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia.
    Ortved D; Hawkins TL; Johnson JA; Hyett J; Metcalfe A
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):239-244. PubMed ID: 29700870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.